Monte Rosa Therapeutics Inc GLUE:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
Last | 12:16 PM EST
9.09quote price arrow up+0.07 (+0.78%)
Volume
44,980
52 week range
6.05 - 22.16
Loading...
  • Open9.20
  • Day High9.20
  • Day Low8.88
  • Prev Close9.02
  • 52 Week High22.16
  • 52 Week High Date12/28/21
  • 52 Week Low6.05
  • 52 Week Low Date06/16/22

Key Stats

  • Market Cap439.96M
  • Shares Out48.40M
  • 10 Day Average Volume0.11M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-55.53

KEY STATS

  • Open9.20
  • Day High9.20
  • Day Low8.88
  • Prev Close9.02
  • 52 Week High22.16
  • 52 Week High Date12/28/21
  • 52 Week Low6.05
  • 52 Week Low Date06/16/22
  • Market Cap439.96M
  • Shares Out48.40M
  • 10 Day Average Volume0.11M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-55.53

RATIOS/PROFITABILITY

  • EPS (TTM)-2.17
  • P/E (TTM)-4.19
  • Fwd P/E (NTM)-3.55
  • EBITDA (TTM)-99.684M
  • ROE (TTM)-30.64%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date03/29/2023(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Monte Rosa Therapeutics Inc

 

Profile

MORE
Monte Rosa Therapeutics, Inc. is a biopharmaceutical company. It is engaged in developing a portfolio of novel small molecule precision medicines that employ the body’s natural mechanisms to selectively degrade therapeutically relevant proteins. It develops a protein degradation platform, called Quantitative and Engineered Elimination of Neosubstrates (QuEEN), that enables it to identify protein targets and molecular glue degrader (MGD), product candidates that are designed...
Alexander Mayweg Ph.D.
Non-Executive Chairman of the Board
Markus Warmuth M.D.
President, Chief Executive Officer, Director
Ajim Tamboli
Chief Financial Officer
Sharon Townson Ph.D.
Chief Technology Officer
Philip Nickson J.D., Ph.D.
General Counsel
Address
645 Summer Street, Suite 102
Boston, MA
02210
United States

Top Peers

SYMBOLLASTCHG%CHG
CMPS
Compass Pathways PLC
10.02-0.89-8.16%
ALXO
ALX Oncology Holdings Inc
10.69+0.08+0.75%
PMVP
PMV Pharmaceuticals Inc
9.72-0.22-2.21%
VIGL
Vigil Neuroscience Inc
12.38+0.48+4.08%
VERA
Vera Therapeutics Inc
15.97-0.33-2.02%